ARDIZZONI, Andrea
 Distribuzione geografica
Continente #
EU - Europa 20.664
NA - Nord America 10.048
AS - Asia 6.404
SA - Sud America 873
AF - Africa 108
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 12
Totale 38.138
Nazione #
IT - Italia 15.616
US - Stati Uniti d'America 9.802
CN - Cina 2.176
SG - Singapore 2.057
GB - Regno Unito 1.582
HK - Hong Kong 804
DE - Germania 704
BR - Brasile 671
FR - Francia 586
SE - Svezia 574
VN - Vietnam 366
RU - Federazione Russa 315
UA - Ucraina 255
FI - Finlandia 227
KR - Corea 221
TR - Turchia 209
NL - Olanda 123
IN - India 120
MX - Messico 115
ID - Indonesia 110
CA - Canada 94
BG - Bulgaria 92
AR - Argentina 88
PL - Polonia 73
JP - Giappone 66
RO - Romania 60
ES - Italia 57
AT - Austria 55
LT - Lituania 50
ZA - Sudafrica 49
CH - Svizzera 48
BE - Belgio 41
IQ - Iraq 40
BD - Bangladesh 39
EC - Ecuador 34
HU - Ungheria 34
IE - Irlanda 32
IR - Iran 30
NO - Norvegia 26
AU - Australia 24
CZ - Repubblica Ceca 24
PK - Pakistan 23
CO - Colombia 22
PT - Portogallo 20
MY - Malesia 18
TH - Thailandia 18
MA - Marocco 16
AE - Emirati Arabi Uniti 15
PE - Perù 15
UZ - Uzbekistan 15
CL - Cile 14
EG - Egitto 14
DK - Danimarca 13
IL - Israele 12
VE - Venezuela 11
DO - Repubblica Dominicana 10
PY - Paraguay 10
EU - Europa 9
GR - Grecia 9
PA - Panama 9
SA - Arabia Saudita 9
PH - Filippine 8
TW - Taiwan 8
KZ - Kazakistan 7
SK - Slovacchia (Repubblica Slovacca) 7
AZ - Azerbaigian 6
HN - Honduras 6
KE - Kenya 6
KG - Kirghizistan 6
RS - Serbia 6
UY - Uruguay 6
DZ - Algeria 5
JO - Giordania 5
LV - Lettonia 5
SI - Slovenia 5
TN - Tunisia 5
HR - Croazia 4
MT - Malta 4
NZ - Nuova Zelanda 4
SM - San Marino 4
SN - Senegal 4
AL - Albania 3
CR - Costa Rica 3
LU - Lussemburgo 3
ML - Mali 3
NP - Nepal 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
GE - Georgia 2
JM - Giamaica 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
MD - Moldavia 2
MK - Macedonia 2
NG - Nigeria 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
Totale 38.120
Città #
Santa Clara 1.441
Singapore 1.375
Southend 963
Hefei 950
Ashburn 929
Hong Kong 780
Chandler 648
Milan 648
Fairfield 591
Rome 590
Bologna 498
Woodbridge 425
Houston 354
Jacksonville 350
Modena 342
London 299
Torino 289
Dearborn 278
Beijing 275
Nyköping 265
Ann Arbor 256
New York 244
Wilmington 244
Los Angeles 242
Florence 230
Seattle 219
Seoul 197
Cambridge 165
Dallas 160
Chicago 157
Catania 145
Helsinki 134
Padova 124
Genova 122
Ho Chi Minh City 112
Munich 108
Moscow 106
Verona 106
Castelnuovo Rangone 104
Venezia 101
Turin 99
Napoli 88
Council Bluffs 87
The Dalles 87
Izmir 86
Sofia 86
Pisa 81
Princeton 81
São Paulo 77
Jakarta 76
Reggio Nell'emilia 76
Hanoi 75
Bari 74
Palermo 74
Naples 72
Bremen 71
Trento 68
Parma 66
San Diego 66
Buffalo 65
Eugene 63
Redwood City 63
Reggio Emilia 60
Salt Lake City 60
Tokyo 60
Trieste 58
Carpi 56
Mexico City 55
Kent 53
Shanghai 51
Bolzano 50
Nuremberg 50
Piemonte 50
Monza 45
Oggiono 45
Udine 45
Pavia 43
Warsaw 42
San Jose 39
Genoa 38
Amsterdam 37
Boardman 37
Des Moines 37
Johannesburg 37
Perugia 36
Guangzhou 35
Messina 35
Nanjing 34
Brussels 33
Denver 33
Rio Saliceto 33
Stockholm 33
Atlanta 31
Brooklyn 31
Columbus 31
Mountain View 31
Paris 31
Phoenix 31
Poplar 31
Orem 30
Totale 18.814
Nome #
RICERCA DI MARCATORI PER LA DIAGNOSI DI INFEZIONE FUNGINA INVASIVAE (IFI) MEDIANTE APPROCCIO DIAGNOSTICO COMBINATO 15.207
Yessotoxin inhibits phagocytic activity of macrophages. 417
Evaluation of benzydamine effects on Candida albicans adhesion, biofilm formation and persistence onto abiotic surfaces 413
DIAGNOSI SIEROLOGICA, MEDIANTE MYCOARRAY, DI UN CASO DI ISTOPLASMOSI DA IMPORTAZIONE IN UN TURISTA ITALIANO DI RITORNO DAL BRASILE 388
A transmissible cytotoxic activity isolated from a patient with brain ischemia causes microglial cell activation and dysfunction 381
A protein microarray immunoassay for the serological evaluation of the antibody response in vertically transmitted infections 379
Genomic and phenotypic variation in morphogenetic networks of two Candida albicans isolates subtends their different pathogenic potential 357
Longitudinal Survey of Fungi in the Human Gut: ITS Profiling, Phenotyping, and Colonization 338
NF-kB activation and p38 phosphorilation in microglial cells infected with Leptospira or exposed to partially purified leptospiral lipoproteins 328
The synthetic killer peptide KP impairs Candida albicans biofilm in vitro 325
Detection of follicular fluid and serum antibodies by protein microarrays in women undergoing in vitro fertilization treatment. 325
Antiviral activity of Hyaluronic Acid 322
In vitro effects of commercial mouthwashes on several virulence traits of Candida albicans, viridans streptococci and Enterococcus faecalis colonizing the oral cavity. 316
Differential efficacy of endodontic obturation procedures: an ex vivo study 315
Real-time monitoring of Pseudomonas aeruginosa biofilm formation on endotracheal tubes in vitro 314
Influence of hyaluronic acid on bacterial and fungal species, including clinically relevant opportunistic pathogens. 309
Lactobacillus acidophilus, L. plantarum, L. rhamnosus, and L. reuteri Cell-Free Supernatants Inhibit Candida parapsilosis Pathogenic Potential upon Infection of Vaginal Epithelial Cells Monolayer and in a Transwell Coculture System In Vitro 301
An antibody reactivity-based assay for diagnosis of invasive candidiasis using protein array 299
A synthetic killer peptide impairs Candida albicans biofilm formation and persistence in vitro 296
Human biliary tree stem/progenitor cells immunomodulation: Role of hepatocyte growth factor 294
I MICROARRAY PROTEICI: POSSIBILI SCENARI NELLA DIAGNOSTICA DELLE MICOSI INVASIVE 292
I MICROARRAY PROTEICI: NUOVI STRUMENTI DI INDAGINE NELLA DIAGNOSTICA DELLE INFEZIONI DA PATOGENI DEL COMPLESSO TORCH. 290
ALTERATA REATTIVITA’ MACROFAGICA IN CORSO DI INFEZIONE MISTA DA VIRUS E FUNGHI:VALUTAZIONI FUNZIONALI, CITOFLUORIMETRICHE E DI ESPRESSIONE GENICA 286
Impact of Candida albicans hyphal wall protein 1 (HWP1) genotype on biofilm production and fungal susceptibility to microglial cells 277
Effects of different mouthwashes on biofilm formation by oral streptococci 276
In vitro evaluation of antiviral and virucidal activity of a high molecular weight hyaluronic acid. 275
Compounds released from Lactobacillus (L.) acidophilus, L. plantarum, L. rhamnosus and L. reuteri inhibit Candida parapsilosis pathogenic potential after infection of vaginal epithelial cells in vitro. 272
Herpes simplex virus type 1 dysregulates anti-fungal defenses preventing monocyte activation and downregulating toll-like receptor-2 267
Antiviral Activity of Synthetic Peptides Derived from Physiological Proteins 266
A New Phenotype in Candida-Epithelial Cell Interaction Distinguishes Colonization- versus Vulvovaginal Candidiasis- Associated Strains 264
Gene expression profiling of monocytes displaying herpes simplex virus 1 induced dysregulation of antifungal defences 255
MESSA A PUNTO DI UN SISTEMA INNOVATIVO PER MONITORARE IN TEMPO REALE LA FORMAZIONE DI BIOFILM DI PSEUDOMONAS AERUGINOSA SU TUBI ENDOTRACHEALI 254
An in vitro and ex vivo study on two antibiotic-based endodontic irrigants: a challenge to sodium hypochlorite 252
Apoptosis and inflammatory response in human astrocytes are induced by a transmissible cytotoxic agent of neurological origin 252
In vitro analysis of epithelial tolerability and anti-Candida effect of a new lactic acid-based vaginal gel formulation 250
Effects of different mouthwashes on Candida albicans adhesion, susceptibility to phagocytic cells and capacity to elicit pro-inflammatory cytokine response 246
CANDIDA ALBICANS HYPHAL DEVELOPMENT AND BIOFILM FORMATION/PERSISTENCE ARE DIFFERENTIALLY AFFECTED BY MOUTHWASHES DEPENDING UPON THEIR COMPOSITION. 242
IL MYCOARRAY: UN TEST RAPIDO PER LA DIAGNOSI SIEROLOGICA DI MICOSI ENDEMICHE 241
DETECTION OF ANTIGEN-SPECIFIC ANTIBODIES IN SERUM AND FOLLICULAR FLUIDS BY PROTEIN MICROARRAYS. 235
The Spr1875 protein confers resistance to the microglia-mediated killing of Streptococcus pneumoniae 231
Diagnostic utility of a microarray based on 11 proteins of Candida albicans for the diagnosis of invasive candidiasis 230
Candida albicans survival, growth and biofilm formation are differently affected by mouthwashes: an in vitro study 230
Anti-Candida and Anti-Inflammatory Properties of a Vaginal Gel Formulation: Novel Data Concerning Vaginal Infection and Dysbiosis 217
COMPARAZIONE DELLA EFFICACIA ANTIBATTERICA DI TETRACLEAN, UN IRRIGANTE ENDODONTICO DI NUOVA GENERAZIONE, CON IPOCLORITO DI SODIO. 214
Wide spectrum activity of a high molecular weight Hyaluronic Acid. 209
Applicazioni del microarray proteico nella diagnosi diretta per la sierotipizzazione di agenti patogeni 209
Caratterizzazione immunobiologica di nuovi antigeni proteici di Streptococcus pneumoniae selezionati mediante "phage display" 208
APPLICAZIONE DEI MICROARRAY PROTEICI NELLA DIAGNOSTICA AVANZATA DI PATOLOGIEMICROBICHE E VIRALI 206
The ABC transporter-encoding gene AFR1 affects the resistance of Cryptococcus neoformans to microglia-mediated antifungal activity by delaying phagosomal maturation. 205
Osteocyte-bone lining cell system responds to cyclic loading in a dose dependent manner 204
Effects of benzydamine and mouthwashes containing benzydamine on Candida albicans adhesion, biofilm formation, regrowth, and persistence 201
Host-microbe interaction in Candida mucosal infections: a complex balance (Interazione ospite-microrganismo nelle infezioni mucosali da Candida: un equilibrio complesso) 198
MICROARRAY PROTEICI NELLA DIAGNOSI DIRETTA: SIEROTIPIZZAZIONE DI AGENTI PATOGENI 195
The protein “mycoarray”: a novel serological assay for the laboratory diagnosis of primitive endemic mycoses 193
PROFILO DELLA RISPOSTA ANTICORPALE A CANDIDA ALBICANS IN DIFFERENTI CATEGORIE DI PAZIENTI A RISCHIO DI INFEZIONI FUNGINE INVASIVE 193
Bacillus coagulans LMG S-24828 Impairs Candida Virulence and Protects Vaginal Epithelial Cells against Candida Infection In Vitro 187
IL MICROARRAY PROTEICO NELL’ANALISI DEI LIQUIDI AMNIOTICI: RICERCA DI MARKER PRECOCI DI INFIAMMAZIONE E/O INFEZIONE CORRELABILI AL PARTO PRETERMINE 185
The Spr1875 protein of Streptococcus pneumoniae protects the bacterium from microglia-mediated killing 185
Comparative in vitro and ex vivo studies on the bactericidal activity of Tetraclean, a new generation endodontic irrigant, and sodium hypochlorite 184
Protein microarrays on midtrimester amniotic fluids: a novel approach for the diagnosis of early intrauterine inflammation related to preterm delivery 175
In vitro and ex vivo studies on the antibacterial efficacy of sodium hypochlorite and two new generation endodontic irrigants, Tetraclean® and MTAD, in comparison with sodium hypochlorite. 173
Perinuclear Anti-Neutrophil Cytoplasmic Antibodies (pANCA) Impair Neutrophil Candidacidal Activity and Are Increased in the Cellular Fraction of Vaginal Samples from Women with Vulvovaginal Candidiasis 173
An Untargeted Metabolomic Analysis of Lacticaseibacillus (L.) rhamnosus, Lactobacillus (L.) acidophilus, Lactiplantibacillus (L.) plantarum and Limosilactobacillus (L.) reuteri Reveals an Upregulated Production of Inosine from L. rhamnosus 172
VALUTAZIONE DEI PROFILI IgG E IgM NEI CONFRONTI DI PATOGENI A TRASMISSIONE VERTICALE IN DIVERSE MATRICI BIOLOGICHE MEDIANTE MICROARRAY PROTEICO 172
The protein “mycoarray”: a novel immunoassay for the serological diagnosis of primitive invasive mycoses 172
The Mycoarray as an aid for diagnosis of an imported case of Histoplasmosis in an Italian traveler returning from Brasil 172
Inhibitory effects of different lactobacilli on Candida albicans hyphal formation and biofilm development. 169
Human herpesvirus-6 dysregulates monocyte-ediated anticryptococcal defences. 168
Sealing ability of gutta-percha in root canals obturated by a modified continuous wave of condensation technique. 167
LA PROTEINA SPR1875 DI STREPTOCOCCUS PNEUMONIAE PROTEGGE IL BATTERIO DAL KILLING DELLA MICROGLIA 166
Il gene AFR1 di Cryptococcus neoformans codificante per un trasportatore ABC, altera la resistenza del patogeno alla microglia: ritardo nella maturazione dei fagosomi. 164
THE PROTECTIVE ROLE OF TYPE-I INTERFERONS AXIS ACTIVATION IN THE VULVOVAGINAL CANDIDIASIS MODEL 161
Candidalysin is a key player in activating vaginal cell ROS in an in vitro infection model 157
It takes two to tango: how a dysregulation of the innate immunity, coupled with Candida virulence, triggers VVC onset 155
Osteocyte-osteoclast morphological relationships and the putative role of osteocytes in bone remodeling. 153
Osteocyte-osteoclast morphological relationships and the putative role of osteocyte in bone remodeling 152
Cell-Free Supernatant from a Strain of Bacillus siamensis Isolated from the Skin Showed a Broad Spectrum of Antimicrobial Activity 149
Fungal burden, dimorphic transition and candidalysin: Role in Candida albicans-induced vaginal cell damage and mitochondrial activation in vitro 146
In vivo colonization and pathogenic potential of C. africana 144
EDTA and Taurolidine affect Pseudomonas aeruginosa virulence in vitro: impairment of secretory profile and biofilm production onto peritoneal dialysis catheters 143
The pathogenic and colonization potential of Candida africana 142
The Propionibacterium spp. extract P40 reduces Candida albicans-induced damage to vaginal epithelial cells and increases mitochondrial response to Candida albicans infection in vitro 136
Establishment of an in vitro model to study co-infection of vaginal epithelium by Candida albicans and Herpes Simplex Virus 2 136
JC-1, but not DiOC6(3) or rhodamine 123, is a reliable fluorescent probe to assess ΔΨ changes in intact cells: Implications for studies on mitochondrial functionality during apoptosis 134
Correlating the physico-chemical properties of two conventional glazed porcelain stoneware tiles in relation to cleanability and sanitization 133
The Propionibacterium spp. extract reduces Candida albicans-induced damage to vaginal epithelial cells and increases mitochondrial response to Candida albicans infection in vitro 124
Acido ialuronico: valutazione della interazione in vitro con batteri e miceti 123
Cutibacterium acnes lysate improves cellular response against Candida albicans, Escherichia coli and Gardnerella vaginalis in an in vitro model of vaginal infection 120
The protective role of type I interferon pathway activation in an in vitro model of vulvovaginal candidiasis 116
Vaginal Clinical Isolates of Candida albicans Differentially Modulate Complosome Activation in Vaginal Epithelial Cells 111
A SEM study on osteocyte proptoplasm by a new technical procedure: preliminary observations 108
Propionibacterium acnes extract improves cellular response against Candida albicans and Escherichia coli in in vitro models of vulvovaginal infections 106
Initial geno-phenotypic characterization of colon mycobiota from healthy donors 105
C. albicans with different genomic background reveal diverse host adaptation and differential processing by phagocytes 102
Histomorphometric analysis of osteoclast effect on osteocyte viability 101
Antigen microarrays for serodiagnosis of infectious diseases 101
Effectiveness of the antibody-derived killer peptide on Candida albicans biofilm 100
Candida albicans as a Trailblazer for Herpes Simplex Virus-2 Infection Against an In Vitro Reconstituted Human Vaginal Epithelium 100
Candida albicans isolates with different genomic backgrounds show diverse host adaptation and differential susceptibility to microgial cell-mediated defenses 94
Does cleanability lead to hygienic ceramic tiles? Investigation of the correlation between the cleanability of ceramic glazes and their antibacterial activity 92
Totale 36.387
Categoria #
all - tutte 99.627
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 99.627


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.532 0 0 0 0 0 0 236 254 213 313 292 224
2021/20222.578 192 185 196 221 146 152 165 184 218 188 388 343
2022/20233.895 339 309 297 340 395 453 213 372 397 175 265 340
2023/20242.771 235 231 237 214 344 262 256 261 110 184 192 245
2024/20256.197 194 169 147 474 1.131 844 433 394 576 348 676 811
2025/20266.634 841 637 943 1.602 1.812 788 11 0 0 0 0 0
Totale 38.568